|
Rabeprazole is an antiulcer drug in the class of proton pump inhibitors. It was developed by Eisai Co. and is available worldwide under many brand names. ==Indications and usage== Short-term treatment in healing and symptomatic relief of duodenal ulcers and erosive or gastroesophageal reflux disease (GERD); maintaining healing and reducing relapse rates of heartburn symptoms in patients with GERD; treatment of daytime and nighttime heartburn and other symptoms associated with GERD; long-term treatment of pathological hypersecretory conditions, including Zollinger-Ellison syndrome and in combination with amoxicillin and clarithromycin to eradicate ''Helicobacter pylori''. *Gastric ulcer (GU) *Peptic ulcer disease (PUD) *Maintenance of healing of erosive or ulcerative GERD *Healing of erosive and ulcerative GERD *Healing of duodenal ulcers. *Treatment of symptomatic GERD *Treatment of pathological hypersecretory conditions (Zollinger-Ellison syndrome) *''Helicobacter pylori'' eradication to reduce risk of duodenal ulcer recurrence 抄文引用元・出典: フリー百科事典『 ウィキペディア（Wikipedia）』 ■ウィキペディアで「Rabeprazole」の詳細全文を読む スポンサード リンク
|